These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30741022)

  • 1. Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study.
    Monfort SM; Pan X; Loprinzi CL; Lustberg MB; Chaudhari AMW
    Integr Cancer Ther; 2019; 18():1534735419828823. PubMed ID: 30741022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy.
    Müller J; Ringhof S; Vollmer M; Jäger LB; Stein T; Weiler M; Wiskemann J
    Gait Posture; 2020 Mar; 77():156-163. PubMed ID: 32036320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
    Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
    Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
    Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
    Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
    Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
    Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
    Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.
    Schwenk M; Grewal GS; Holloway D; Muchna A; Garland L; Najafi B
    Gerontology; 2016; 62(5):553-63. PubMed ID: 26678611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy.
    Kneis S; Wehrle A; Freyler K; Lehmann K; Rudolphi B; Hildenbrand B; Bartsch HH; Bertz H; Gollhofer A; Ritzmann R
    Clin Neurophysiol; 2016 Feb; 127(2):1481-1490. PubMed ID: 26350407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention.
    Kneis S; Wehrle A; Dalin D; Wiesmeier IK; Lambeck J; Gollhofer A; Bertz H; Maurer C
    BMC Neurol; 2020 Jan; 20(1):23. PubMed ID: 31948403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
    Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
    BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
    Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
    Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
    Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
    Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
    BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fall Risk Associated with Taxanes: Focus on Chemotherapy-Induced Peripheral Neuropathy.
    Visovsky C; Wodzinski PT; Haladay D; Ji M; Coury J
    Semin Oncol Nurs; 2024 Aug; 40(4):151687. PubMed ID: 39013733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control.
    Müller J; Kreutz C; Ringhof S; Koeppel M; Kleindienst N; Sam G; Schneeweiss A; Wiskemann J; Weiler M
    Sci Rep; 2021 Jan; 11(1):2398. PubMed ID: 33504885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy.
    Vollmers PL; Mundhenke C; Maass N; Bauerschlag D; Kratzenstein S; Röcken C; Schmidt T
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1785-1792. PubMed ID: 29943097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy.
    Wampler MA; Topp KS; Miaskowski C; Byl NN; Rugo HS; Hamel K
    Arch Phys Med Rehabil; 2007 Aug; 88(8):1002-8. PubMed ID: 17678662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.